CIK: 0001232621
Total reported value
$2.0B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Salix Pharmaceuticals INC | Stock-Other | 24.29% | — | — | |
| 2 | HRTX | Heron Therapeutics INC | Stock-Other | 21.23% | -0.15% | — | |
| 3 | PDLI 2.875 02-15-15 * | Pdl Bio Pharma INC | Stock-Other | 19.41% | — | — | |
| 4 | OPK 3 02-01-33 144A | Opko Health INC | Stock-Other | 9.72% | — | — | |
| 5 | LJPC | La Jolla Pharmaceutical Co | Stock-Other | 9.52% | — | +116.74% | |
| 6 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 6.82% | — | — | |
| 7 | MACK 4.5 07-15-20 | Merrimack Pharmaceuti | Stock-Other | 4.40% | — | — | |
| 8 | MRTXEUR | Mirati Therapeutics INC | Stock-Other | 2.62% | — | — | |
| 9 | ✓ | Horizon Pharma PLC | Stock-Other | 1.91% | — | — | |
| 10 | ✓ | Rxi Pharmaceuticals CORP | Stock-Other | 0.05% | — | — | |
| 11 | ✓ | Dendreon CORP | Stock-Other | 0.04% | — | — | |
| 12 | ✓ | Ambit Biosciences CORP | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Salix Pharmaceuticals INC | +7.2% | — | Unchanged |
| 2 | LJPC | La Jolla Pharmaceutical Co | +5.8% | +116.74% | Add |
| 3 | BMRN | Biomarin Pharmaceutical INC | +1.6% | — | Unchanged |
| 4 | OPK 3 02-01-33 144A | Opko Health INC | +1% | — | Unchanged |
| 5 | MACK 4.5 07-15-20 | Merrimack Pharmaceuti | +0.9% | — | Unchanged |
| 6 | ✓ | Ambit Biosciences CORP | — | — | Unchanged |
| 7 | ✓ | Dendreon CORP | 0% | — | Unchanged |
| 8 | MRTXEUR | Mirati Therapeutics INC | -0.1% | — | Unchanged |
| 9 | PDLI 2.875 02-15-15 * | Pdl Bio Pharma INC | -2.8% | — | Unchanged |
| 10 | HRTX | Heron Therapeutics INC | -6.8% | — | Unchanged |
| 11 | ✓ | Horizon Pharma INC | — | EXIT | Sold out |
| 12 | ✓ | Horizon Pharma PLC | — | NEW | New buy |
| 13 | ✓ | Endocyte INC | — | EXIT | Sold out |
| 14 | ✓ | Rxi Pharmaceuticals CORP | — | NEW | New buy |